Mouse Anti-FMNL2 Recombinant Antibody (CBXF-0771) (CBMAB-F0441-CQ)

Lee, A. J., Raghavan, N. S., Bhattarai, P., Siddiqui, T., Sariya, S., Reyes-Dumeyer, D., ... & Mayeux, R. (2022). FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease. Acta neuropathologica, 144(1), 59-79.

Katsuno‐Kambe, H., Parton, R. G., Yap, A. S., & Teo, J. L. (2021). Caveolin‐1 influences epithelial collective cell migration via FMNL2 formin. Biology of the Cell, 113(2), 107-117.

Dimchev, V., Lahmann, I., Koestler, S. A., Kage, F., Dimchev, G., Steffen, A., ... & Rottner, K. (2021). Induced Arp2/3 complex depletion increases FMNL2/3 formin expression and filopodia formation. Frontiers in cell and developmental biology, 9, 634708.

Li, J., & Yan, S. (2021). MiR-466 inhibits the progression of severe hepatocellular carcinoma via regulating FMNL2-mediated activation of NF-κB and Wnt/β-catenin pathways. Journal of Oncology, 2021.

Yan, Y., Su, M., & Qin, B. (2020). CircHIPK3 promotes colorectal cancer cells proliferation and metastasis via modulating of miR-1207-5p/FMNL2 signal. Biochemical and biophysical research communications, 524(4), 839-846.

Pfisterer, K., Levitt, J., Lawson, C. D., Marsh, R. J., Heddleston, J. M., Wait, E., ... & Parsons, M. (2020). FMNL2 regulates dynamics of fascin in filopodia. Journal of Cell Biology, 219(5).

Yan, Y., Wang, Z., & Qin, B. (2019). A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC. Biochemical and biophysical research communications, 509(2), 441-447.

Shao, H. J., Li, Q., Shi, T., Zhang, G. Z., & Shao, F. (2019). LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis. Eur Rev Med Pharmacol Sci, 23(9), 3749-3759.

Ren, X. L., Qiao, Y. D., Li, J. Y., Li, X. M., Zhang, D., Zhang, X. J., ... & Liang, L. (2018). Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation. Cancer letters, 419, 245-256.

Chen, F., Zhang, Q., Wang, Y., Wang, S., Feng, S., Qi, L., ... & Ding, C. (2018). KIT, NRAS, BRAF and FMNL2 mutations in oral mucosal melanoma and a systematic review of the literature. Oncology Letters, 15(6), 9786-9792.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols